Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Review on Candida Auris, an Emerging Drug-Resistant Fungal Pathogen Publisher



Safari F1 ; Ahmadikia K2 ; Mirhendi H3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran
  2. 2. Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2022


Abstract

Candida auris, a multidrug-resistant yeast, can cause primary or secondary infections in a wide range of patients, including those diagnosed with the new coronavirus to even healthy individuals. The fungus has been reported in less than a decade on all six continents and in more than 45 countries. Ease of distribution, long shelf life, and resistance to several antifungal drugs have raised concerns about the prevention and management of patients with C. auris infection. Recent reports indicate serious challenges in identifying, understanding the mechanism of drug resistance, and preventing mortality from the infection with this microorganism. Given the prevalence of COVID-19 infection, it is important to identify patients colonized with C. auris correctly and at the early stages, to control and prevent a possible outbreak. In this article, the widespread occurrence of infections due to C. auris in the world and Iran, its clinical manifestations, risk factors, pathogenic mechanisms, diagnostic enhancements and challenges, drug resistance, treatment options, prevention, and control as well as concomitant C. auris infections in patients with COVID-19 virus, are reviewed. © 2022 Isfahan University of Medical Sciences(IUMS). All rights reserved.
Related Docs
View other Related Docs
1. Molecular Investigation of the Incidence of Candida Auris Infections at Selected Hospitals in Iran, Mycoses (2022)
2. Methods for Identification of Candida Auris, the Yeast of Global Public Health Concern: A Review, Journal de Mycologie Medicale (2019)
3. South Asian (Clade I) Candida Auris Meningitis in a Paediatric Patient in Iran With a Review of the Literature, Mycoses (2022)
4. A Chronic Autochthonous Fifth Clade Case of Candida Auris Otomycosis in Iran, Mycopathologia (2022)
5. Confirmation of Fifth Candida Auris Clade by Whole Genome Sequencing, Emerging Microbes and Infections (2022)
6. Yeast Species in the Respiratory Samples of Covid-19 Patients; Molecular Tracking of Candida Auris, Frontiers in Cellular and Infection Microbiology (2024)
7. Fatal Invasive Pulmonary Aspergillosis in Covid-19 Patient With Acute Myeloid Leukemia in Iran, Mycopathologia (2020)
8. Fatal Disseminated Aspergillosis in an Immunocompetent Patient With Covid-19 Due to Aspergillus Ochraceus, Journal of Medical Mycology (2021)
Experts (# of related papers)
View all Related Experts
Seyed Hossein Mirhendi Esfahani (30)
Rasoul Mohammadi (30)
Other Related Docs
9. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
10. Covid‑19‑Associated Mucormycosis: A Review of an Emergent Epidemic Fungal Infection in the Era of Covid‑19 Pandemic, Journal of Research in Medical Sciences (2022)
11. Low Level of Antifungal Resistance in Iranian Isolates of Candida Glabrata Recovered From Blood Samples in a Multicenter Study From 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of Pdr1, Antimicrobial Agents and Chemotherapy (2019)
12. Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia in Intensive Care Units in Isfahan, Iran, Current Medical Mycology (2022)
13. Multicenter Identification and Antifungal Susceptibility Patterns of Candida Species Isolated From Clinical Samples, Jundishapur Journal of Microbiology (2017)
14. The Double-Edged Sword of Systemic Corticosteroid Therapy in Viral Pneumonia: A Case Report and Comparative Review of Influenza-Associated Mucormycosis Versus Covid-19 Associated Mucormycosis, Mycoses (2021)
15. Differentiation of Candida Albicans Complex Species Isolated From Invasive and Non-Invasive Infections Using Hwp1 Gene Size Polymorphism, Current Medical Mycology (2021)
16. Detection of Erg11 Point Mutations in Iranian Fluconazole-Resistant Candida Albicans Isolates, Current Medical Mycology (2019)
17. Current Status of Covid-19 Pandemic; Characteristics, Diagnosis, Prevention, and Treatment, Journal of Research in Medical Sciences (2020)
18. Clinical and Mycological Study of Vulvovaginal Candidiasis (Vvc); Identification of Clinical Isolates by Polymerase Chain Reaction-Fragment Size Polymorphyim (Pcr-Fsp) Technique, Archives of Clinical Infectious Diseases (2017)
19. Candidemia in Children Caused by Uncommon Species of Candida, Archives of Pediatric Infectious Diseases (2018)
20. Antifungal Effect of Atorvastatin Against Candida Species in Comparison to Fluconazole and Nystatin, Medicine and Pharmacy Reports (2019)
21. Controlling and Prevention of Novel Coronavirus Through Health and Safety Protocols in Food: Review Article, Tehran University Medical Journal (2021)
22. Identification and Frequency of Candida Species in Patients With Different Forms of Candidiasis in Isfahan, Using Pcr-Rflp Method, Journal of Isfahan Medical School (2011)
23. An Alarming Rise of Non-Albicans Candida Species and Uncommon Yeasts in the Clinical Samples; a Combination of Various Molecular Techniques for Identification of Etiologic Agents, BMC Research Notes (2019)
24. In Vitro Activities of Six Antifungal Drugs Against Candida Glabrata Isolates: An Emerging Pathogen, Jundishapur Journal of Microbiology (2016)
25. Molecular Identification and Antifungal Susceptibility Profiles of Etiologic Agents of Oral Candidiasis Among Hiv-Positive Patients: A Multicenter Study, Current Medical Mycology (2023)
26. The Evaluation of the Overexpression of the Erg-11, Mdr-1, Cdr-1, and Cdr-2 Genes in Fluconazole-Resistant Candida Albicans Isolated From Ahvazian Cancer Patients With Oral Candidiasis, Journal of Clinical Laboratory Analysis (2022)
27. Amino Acid Substitutions in Erg11p of Azole-Resistant Candida Glabrata: Possible Effective Substitutions and Homology Modelling, Journal of Global Antimicrobial Resistance (2016)
28. Effect of Curcumin-Pipeine Supplementation on Clinical Status, Mortality Rate, Oxidative Stress, and Inflammatory Markers in Critically Ill Icu Patients With Covid-19: A Structured Summary of a Study Protocol for a Randomized Controlled Trial, Trials (2021)
29. The Frequency of Oral Candidiasis in Children and Adolescents With Leukemia in Isfahan Province, Iran, Journal of Isfahan Medical School (2017)
30. Prevalence, Molecular Identification, and Genotyping of Candida Species Recovered From Oral Cavity Among Patients With Diabetes Mellitus From Tehran, Iran, Advanced Biomedical Research (2022)
31. Covid-19 Associated Mucormycosis Surge: A Review on Multi-Pathway Mechanisms, Parasite Immunology (2024)
32. The Covid-19 Pandemic: A Systematic Review of the Current Evidence; [Пандемия Covid-19: Систематический Обзор Современных Данных], Russian Journal of Infection and Immunity (2020)
33. Epidemiology and Antifungal Susceptibility of Candida Species Isolated From 10 Tertiary Care Hospitals in Iran, Microbiology Spectrum (2022)
34. Microbial and Clinical Epidemiology of Invasive Fungal Rhinosinusitis in Hospitalized Covid-19 Patients, the Divergent Causative Agents, Medical Mycology (2023)
35. The Effects of Nutraceuticals and Herbal Medicine on Candida Albicans in Oral Candidiasis: A Comprehensive Review, Advances in Experimental Medicine and Biology (2021)
36. Immunomodulatory Drug Fingolimod (Fty720) Restricts the Growth of Opportunistic Yeast Candida Albicans in Vitro and in a Mouse Candidiasis Model, PLoS ONE (2022)
37. Demographic Characteristics of the Patients With Cutaneous Vasculitis Due to Covid-19 Infection, Indian Journal of Dermatology (2022)
38. Features and Evaluation of Mucormycosis in Covid-19 Patients From Two Referral Hospitals in Iran, Journal of Medical Mycology (2024)
39. Epidemiologic and Antifungal Susceptibility Profile of Candiduria Among Patients Hospitalized in the Nephrology and Intensive Care Unit Wards, Tehran, Iran, Jundishapur Journal of Microbiology (2022)
40. Utilization of Size Polymorphism in Its1 and Its2 Regions for Identification of Pathogenic Yeast Species, Journal of Medical Microbiology (2017)
41. Caspofungin-Non-Susceptible Candida Orthopsilosis Isolated From Onychomycosis in Iran, Iranian Journal of Public Health (2017)
42. Functional Analysis of Two Stat1 Gain-Of-Function Mutations in Two Iranian Families With Autosomal Dominant Chronic Mucocutaneous Candidiasis, Medical Mycology (2021)
43. Frequency of Uncommon Clinical Yeast Species Confirmed by Its-Sequencing, Archives of Clinical Infectious Diseases (2019)
44. Candida Africana Vulvovaginitis: Prevalence and Geographical Distribution, Journal de Mycologie Medicale (2020)
45. Rapid Detection of Candida Species in Bronchoalveolar Lavage Fluid From Patients With Pulmonary Symptoms, Brazilian Journal of Microbiology (2016)
46. Invasive Fusarium Rhinosinusitis in Covid-19 Patients: Report of Three Cases With Successful Management, Frontiers in Cellular and Infection Microbiology (2023)
47. Microbial Epidemiology of Candidaemia in Neonatal and Paediatric Intensive Care Units at the Children's Medical Center, Tehran, Mycoses (2018)
48. The First Case of Wickerhamomyces Anomalus Fungemia in Iran in an Immuneodeficient Child, a Review on the Literature, Journal of Medical Mycology (2023)
49. Global Prevalence, Mortality, and Main Risk Factors for Covid-19 Associated Pneumocystosis: A Systematic Review and Meta-Analysis, Asian Pacific Journal of Tropical Medicine (2022)
50. Candida Palmioleophila Candidemia and Bacterial Co-Infection in a 3-Month-Old Infant With Biliary Atresia, Frontiers in Cellular and Infection Microbiology (2023)